Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Bioorganic & Medicinal Chemistry
|
June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death
Ping Jun Zhu, John P Hobson, Noel Southall, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2010
Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax
Keith L Wycoff, Archana Belle, Dorothée Deppe, et al.
The Journal of Biological Chemistry
|
November 3, 2007
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature
Shihui Liu, Hailun Wang, Brooke M Currie, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2022
Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases
Nadire Duru, Nisha R Pawar, Erik W Martin, et al.
Translational Oncology
|
October 27, 2015
Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)
Amira Bekdash, Manal Darwish, Zahra Timsah, et al.
Journal of Translational Medicine
|
January 15, 2026
Nrf2 overexpression reprograms neural stem cell fate: promoting neuronal differentiation and functional recovery post-ischemic stroke via suppression of the ROS/NF-κB axis
Pengyu Hao, Shihui Liu, Ying Wang, et al.
Toxins
|
September 29, 2020
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells
Jonathan Mackowiak da Fonseca, Ivone Izabel Mackowiak da Fonseca, Marcia Kazumi Nagamine, et al.
Veterinary Research Communications
|
May 28, 2024
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study
Ivone Izabel Mackowiak da Fonseca, Márcia Kazumi Nagamine, Luciana Boffoni Gentile, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase-Activated Anthrax Proteins
Mary-Ann Elvina Xavier, Shihui Liu, Thomas H Bugge, et al.
The Journal of Biological Chemistry
|
February 9, 2013
Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors
Damilola D Phillips, Rasem J Fattah, Devorah Crown, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Bioorganic & Medicinal Chemistry
|
June 23, 2009
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death
Ping Jun Zhu, John P Hobson, Noel Southall, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2010
Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax
Keith L Wycoff, Archana Belle, Dorothée Deppe, et al.
The Journal of Biological Chemistry
|
November 3, 2007
Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature
Shihui Liu, Hailun Wang, Brooke M Currie, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 2022
Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases
Nadire Duru, Nisha R Pawar, Erik W Martin, et al.
Translational Oncology
|
October 27, 2015
Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)
Amira Bekdash, Manal Darwish, Zahra Timsah, et al.
Journal of Translational Medicine
|
January 15, 2026
Nrf2 overexpression reprograms neural stem cell fate: promoting neuronal differentiation and functional recovery post-ischemic stroke via suppression of the ROS/NF-κB axis
Pengyu Hao, Shihui Liu, Ying Wang, et al.
Toxins
|
September 29, 2020
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells
Jonathan Mackowiak da Fonseca, Ivone Izabel Mackowiak da Fonseca, Marcia Kazumi Nagamine, et al.
Veterinary Research Communications
|
May 28, 2024
Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study
Ivone Izabel Mackowiak da Fonseca, Márcia Kazumi Nagamine, Luciana Boffoni Gentile, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase-Activated Anthrax Proteins
Mary-Ann Elvina Xavier, Shihui Liu, Thomas H Bugge, et al.
The Journal of Biological Chemistry
|
February 9, 2013
Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors
Damilola D Phillips, Rasem J Fattah, Devorah Crown, et al.
Page
of 17